MELBOURNE, Australia, Oct. 04, 2024 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN), is an Australian based and globally integrated biopharmaceutical company that has developed two ...
ILiAD Biotechnologies, LLC (ILiAD), an advanced clinical stage biotech company focused on the prevention and treatment of disease caused by Bordetella Pertussis, today announced the peer-reviewed ...
An investigational oral, live-attenuated vaccine for Salmonella serovar Paratyphi A — CVD 1902 — provided significant protection against S Paratyphi A infection in healthy adults in a phase 2 ...
Saint Herblain (France) and Schlieren (Zurich), November 13, 2024 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, and LimmaTech Biologics AG, a clinical-stage biotech ...
Flannery B, Chung JR, Belongia EA, et al. Interim estimates of 2017-18 seasonal influenza vaccine effectiveness - United States, February 2018. MMWR Morb Mortal Wkly Rep 2018; 67:180–5. 2. Dharan NJ, ...
NANTES, France & VIENNA, Austria & HEIDELBERG, Germany--(BUSINESS WIRE)--Naobios, a CDMO providing bioprocess development and good manufacturing practices (GMP) production of clinical batches of virus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback